In 1898 Tesla published an article in The Electrical Engineer17 discussing the therapeutic use of one of his inventions:
“The physician will now be able to obtain an instrument suitable to fulfill many requirements. He will be able to use it in electro-therapeutic treatment in most of the ways enumerated. He will have the facility of providing himself with coils such as he may desire to have for any particular purpose, which will give him any current or any pressure he may wish to obtain. Such coils will consist of but a few turns of wire, and the expense of preparing them will be quite insignificant. The instrument will also enable him to generate Rontgen rays of much greater power than obtainable with ordinary apparatus. A tube must still be furnished by the manufacturers which will not deteriorate and which will allow to concentrate larger amounts of energy upon the electrodes. When this is done, nothing will stand in the way of an extensive and efficient application of this beautiful discovery which must ultimately prove itself of the highest value, not only at the hands of the surgeon, but also of the electro-therapist and, what is most important, of the bacteriologist.”
On the other coast of the U.S., another brilliant pioneer birthed the idea to investigate the possibilities of electrical treatment of diseases. The place was San Diego and his name was Royal Raymond Rife. He was fascinated by bacteriology, microscopes and electronics. He noticed individual differences in the chemical constituents of disease organisms and saw the indication of electrical characteristics, and observed electrical polarities in the organisms.18 Over the next 30-years he proved the efficacy of using focused specific resonant frequencies destroying disease organisms and eliminating chronic disease including cancer.
As history continued, on October 13, 2009 Goodwin et al at NASA (The National Aeronautics and Space Administration) filed Patent No: US 7,601,114 B2 for an electromagnetic apparatus using a wire coil to enhance tissue repair in mammals. On August 15, 2005 NASA released an article entitled Pulsed Electromagnetic Fields – A Countermeasure for Bone Loss and Muscle Atrophy19 confirming the need of stimulating their astronauts with non-invasive pulsating electromagnetic fields during the time they live in space and are disconnected from earth’s energy/gravity to help prevent bone loss and muscle atrophy.
CASE HISTORIES
RL, a 5-Year-Old Male Diagnosed with Thrombosis on the Heart Valve
Patient has pacemaker after open-heart surgery at age 2 performed at Children’s Hospital in Boston (Corrected L-transposition, closure of VSD). In March of 2002, patient was diagnosed with a thrombus measuring 10mm x 0.9mm located on heart valve. He had been on an average of 2 mg Coumadin for 2-months, but had not yet reached a therapeutic level, which was set between 2-3 (INR). His blood results came back as 1.75, 1.8, 3.8 and 4.2.
Head cardiologist David Fulton, M.D. an assistant professor at Harvard Medical School, was considering surgically removing the thrombus due to the non-responsiveness of the patient to Coumadin. To potentially avoid surgery, the therapeutic approach of biofeedback and focused field stimulation was added to the treatment of the anti-coagulant.
The frequencies emitted from the technology were tested at Children’s Hospital at Westchester Medical Center, NY, for possible interference with pacemaker. There were no fluctuations of the pacemaker or in the heart as seen on the echocardiogram as well as pacemaker testing device from Medtronic. Three therapeutic sessions were administered within 4-days; scanning and applying patient specific frequencies. The patient’s reaction areas were noted in patient data sheet and were stimulated with the patient-specific frequencies. Another INR blood test was taken several days later and for the first time in 3-months, RL reached a therapeutic level of 2.7.
Two additional biofeedback and focused field stimulation therapies were administered over the following 5-days. After only 5 treatments over 2-weeks, the patient was examined with an echocardiogram at Westchester Medical Center, NY, which showed a reduction of the thrombus to 0.9mm x 0.6mm. Patient continued the sessions weekly. Three weeks later another echocardiogram showed that the thrombosis had further reduced to 0.6mm x 0.5mm.
Patient received sessions every 2-weeks with individual frequencies and pre-set programs. Just 3-months later, patient’s thrombosis was barely visible on the echocardiogram and patient was taken off the Coumadin medication. Patient successfully avoided having to go through open-heart surgery by adding biofeedback & focused field stimulation therapy to the existing treatment protocol. According to pediatric cardiologist Aaron Levine, M.D. Children’s Hospital at Westchester Medical Center, who stated in his letter dated October 2003 to the patient’s pediatrician:
“The thrombus as described in previous letters by Dr. Woolf is not clearly seen at this examination”.
The patient remains in good health, without any medication and quarterly maintenance treatment. He is now 17-years-old (July 2014) and recent examination at the University Clinic in Freiburg, Germany, revealed a healthy heart without any signs of a thrombus.
Myasthenia Gravis
JP, a 59-year-old female has had 17 treatments with a technology combining biofeedback and focused field stimulation as of March 26, 2010. She was diagnosed with myasthenia gravis after initial testing for multiple sclerosis in her 40's. Her symptoms included:
•Muscle weakness over whole body increasing with use;
•Drooping eyelid on right side;
•Sagging face on right side;
•Lack of facial expression on right side;
•Weakness of the hand muscle;
•Urgency incontinence;
•Extreme tiredness in daytime;
•Sleep disturbance at night;
•Equilibrium/Balance problems;
•Arrhythmia.
Treatment was started on January 18, 2010. By her fifth session, she started resting better. By March, she reported sleeping 6-hours at night undisturbed. The muscle tone of her face greatly improved (Fig. 2). Within a total of 17 treatments over 4-months, the patient no longer experienced any of the symptoms as part of her diagnosis. JP reported her cardiologist adjusted the arrhythmia medication since her cardiac diagnosis of arrhythmia showed significant improvement. The patient is followed up with maintenance treatment once per quarter.
Figure 2. JP before (left) and after (right) undergoing 17 treatments over 4-months
Lymphedema
Suzanne Somers, a well-known health pioneer and best-selling author, has published several books over the past years revealing groundbreaking medical approaches that are used in daily practice by progressive physicians around the U.S. She has written of her use of biofeedback combined with focused field stimulation in Breakthrough, Knockout, and Bombshell and revealed how this modality helped her with lymphedema by alleviating the swelling and pain from her left axilla and left breast using this therapeutic approach. Interesting was the fact, that her main reaction area was not in the area of the swelling, but in the right lower quadrant where the focused field stimulation primarily took place. She confirmed the location of a scar. This is a perfect example to showcase the correlation between stagnation of fluid or energy in a remote area being the root cause to the accumulation of fluid or energy in a different part of the body; In this case the correlation was between the scar on the right lower abdomen and the left axilla/breast. Suzanne has been using this modality